The Duke University Graduate Program in Immunology proposes a continuation of its Basic Immunology Training Program. The main goal of the Training Program is to select talented predoctoral candidates and to prepare them, through formal coursework, seminars, and independent research, for outstanding and productive research careers in basic immunology. The training faculty consists of 22 immunologists who hold primary or secondary appointments in the Department of Immunology. This faculty provides trainees with opportunities for rigorous training in a range of areas of contemporary immunologic research, for example: mechanisms of lymphocyte development and function, including lymphoid lineage commitment, V(D)J recombination, lymphocyte signaling, effector cell development, homeostasis, and tolerance;mechanisms of innate immunity and inflammation, including macrophage, dendritic cell, mast cell and complement function;mechanisms of host defense against bacterial and viral pathogens;the development of autoimmune and immunodeficiency diseases;and anti-tumor immunity. Funds are sought to support the training of four students per year. A selections committee will choose for support the most outstanding predoctoral trainees from among students accepted into the Graduate Program in Immunology. These students will receive support during their first and second years, until their admission to doctoral candidacy and the initiation of dissertation research. A carefully crafted core curriculum will provide trainees with superb grounding in basic immunology, cell biology, molecular biology and genetics. The Basic Immunology Training Program will teach the next generation of U.S. researchers the critical skills they will need to perform outstanding basic immunologic research. Future discoveries by these researchers will be absolutely essential for our continued progress in the fights against infectious diseases, cancer, and autoimmune and immunodeficiency diseases.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Allergy & Clinical Immunology-1 (AITC)
Program Officer
Prograis, Lawrence J
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
Schools of Medicine
United States
Zip Code
Lai, Anne Y; Watanabe, Akiko; O'Brien, Tommy et al. (2009) Pertussis toxin-sensitive G proteins regulate lymphoid lineage specification in multipotent hematopoietic progenitors. Blood 113:5757-64
Kikuchi, Kazu; Kasai, Hirotake; Watanabe, Akiko et al. (2008) IL-7 specifies B cell fate at the common lymphoid progenitor to pre-proB transition stage by maintaining early B cell factor expression. J Immunol 181:383-92
Hudson, Lori L; Louise Markert, M; Devlin, Blythe H et al. (2007) Human T cell reconstitution in DiGeorge syndrome and HIV-1 infection. Semin Immunol 19:297-309
Lai, Anne Y; Kondo, Motonari (2007) Identification of a bone marrow precursor of the earliest thymocytes in adult mouse. Proc Natl Acad Sci U S A 104:6311-6
Draper, David W; Bethea, Heather N; He, You-Wen (2006) Toll-like receptor 2-dependent and -independent activation of macrophages by group B streptococci. Immunol Lett 102:202-14
Lai, Anne Y; Kondo, Motonari (2006) Asymmetrical lymphoid and myeloid lineage commitment in multipotent hematopoietic progenitors. J Exp Med 203:1867-73
Hsu, Chia-Lin; King-Fleischman, Angela G; Lai, Anne Y et al. (2006) Antagonistic effect of CCAAT enhancer-binding protein-alpha and Pax5 in myeloid or lymphoid lineage choice in common lymphoid progenitors. Proc Natl Acad Sci U S A 103:672-7
Lai, Anne Y; Lin, Simon M; Kondo, Motonari (2005) Heterogeneity of Flt3-expressing multipotent progenitors in mouse bone marrow. J Immunol 175:5016-23
Jackson, Annette; Kondilis, Hrisavgi D; Khor, Bernard et al. (2005) Regulation of T cell receptor beta allelic exclusion at a level beyond accessibility. Nat Immunol 6:189-97
Kikuchi, Kazu; Lai, Anne Y; Hsu, Chia-Lin et al. (2005) IL-7 receptor signaling is necessary for stage transition in adult B cell development through up-regulation of EBF. J Exp Med 201:1197-203

Showing the most recent 10 out of 14 publications